Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 23 results for "Mantle Cell Lymphoma (MCL)".

Thumbnail for Concurrent High-Risk Features in Mantle Cell Lymphoma: Frequency and Impact

MCL - 1013

Concurrent High-Risk Features in Mantle Cell Lymphoma: Frequency and Impact

Carla Isabel Borre

Poster Presenter: Carla Isabel Borre

Thumbnail for ???????? ??? ?????? ?? ??????????? (???-?????/???????) ?? ????????/?????????? ?????? ???? ????????: ? ?????????? ?????? ??? ????-????????

MCL - 1024

???????? ??? ?????? ?? ??????????? (???-?????/???????) ?? ????????/?????????? ?????? ???? ????????: ? ?????????? ?????? ??? ????-????????

Edith Ramos Ocola

Poster Presenter: Edith Ramos Ocola

Thumbnail for Therapeutic Implications of TP53 and High-Risk Genomic Alterations in Mantle Cell Lymphoma: A Systematic Review

Previous 1 2 3 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MCL - 1190

Therapeutic Implications of TP53 and High-Risk Genomic Alterations in Mantle Cell Lymphoma: A Systematic Review

Sunanda Chagam Reddy

Poster Presenter: Sunanda Chagam Reddy

Thumbnail for Clinical Outcomes Following Ibrutinib Withdrawal in Mantle Cell Lymphoma: A TriNetX Analysis

MCL - 1233

Clinical Outcomes Following Ibrutinib Withdrawal in Mantle Cell Lymphoma: A TriNetX Analysis

Kumar Anmol

Poster Presenter: Kumar Anmol

Thumbnail for Pirtobrutinib-First vs Brexucabtagene Autoleucel-First Sequencing Post Covalent BTK Inhibitor Failure in Mantle Cell Lymphoma: A Propensity-Matched Real-World Analysis

MCL - 1257

Pirtobrutinib-First vs Brexucabtagene Autoleucel-First Sequencing Post Covalent BTK Inhibitor Failure in Mantle Cell Lymphoma: A Propensity-Matched Real-World Analysis

Kumar Anmol

Poster Presenter: Kumar Anmol

$Thumbnail for Treatment Patterns and Clinical Outcomes Among Patients With Treatment-Naοve and Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) in Community Practice Between 2020 and 2025$

MCL - 1296

Treatment Patterns and Clinical Outcomes Among Patients With Treatment-Naοve and Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) in Community Practice Between 2020 and 2025

Javier Munoz

Poster Presenter: Javier Munoz

Thumbnail for Autologous Stem Cell Transplantation Remains an Effective Strategy in Mantle Cell Lymphoma in a Brazilian Real-World Cohort

MCL - 1435

Autologous Stem Cell Transplantation Remains an Effective Strategy in Mantle Cell Lymphoma in a Brazilian Real-World Cohort

Lara Gallucci Figorelle

Poster Presenter: Lara Gallucci Figorelle

Thumbnail for Real-World CAR-T Utilization and Competing Mortality Following Covalent BTKi Therapy in Mantle Cell Lymphoma

MCL - 1460

Real-World CAR-T Utilization and Competing Mortality Following Covalent BTKi Therapy in Mantle Cell Lymphoma

Alexandra Miller

Poster Presenter: Alexandra Miller

Thumbnail for Second Primary Malignancies After Mantle Cell Lymphoma: A Population-Based SEER Analysis of Cancer-Specific and Long-Term Risk

MCL - 1551

Second Primary Malignancies After Mantle Cell Lymphoma: A Population-Based SEER Analysis of Cancer-Specific and Long-Term Risk

Muhammad Sarfraz Khan

Poster Presenter: Muhammad Sarfraz Khan

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.